<!DOCTYPE html>
<html lang="en">
<head><!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-N4XZHNC');</script> <!-- End Google Tag Manager -->

<title>Axitinib: Indications, Adverse Effects, Contraindications and Dosage</title>
  <meta charset="utf-8">
  
  <link href="urology2.css" rel="stylesheet">

<meta name="keywords" content="Axitinib, Axitinib, renal cell carcinoma" >
<meta name="description" content="Pharmacology, side effects and contraindications of axitinib, from the online textbook of urology by D. Manski" >
<meta name="author" content="Dr. med. Dirk Manski" >
<meta name="copyright" content="Dirk Manski" >
<meta name="robots" content="index">
<meta name="robots" content="follow">
<meta name="viewport" content="width=device-width, initial-scale=1">
 </head>

<body><!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N4XZHNC" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
<header>
    <a class="ribbon" tabindex="-1" title="back to start!" href="https://www.urology-textbook.com/index.html">
	   <p><span style="font-size: 1.2em;">Urology Textbook</span><br>
       
       <span style="font-size: 0.8em;">Clinical Essentials</span>
       <br>
       <span style="font-size: 0.6em;">By Dirk Manski, MD</span></p>
    </a>  
</header>
<main> 
<article>
<nav role="navigation">
<div id="menuToggle">
<input type="checkbox" id="menuCheckbox" />
     <span></span>
    <span></span>
    <span></span>
<ul id="menu">
<li>
        <a href="https://www.urology-textbook.com/anatomy.html">
          <label for="menuCheckbox" onclick="this.parentNode.click();">Anatomy</label>
        </a>
      </li>
<li><a href="https://www.urology-textbook.com/signs-and-symptoms.html">Signs and Symptoms</a></li>
<li><a href="https://www.urology-textbook.com/examinations.html">Examinations</a></li>
<li><a href="https://www.urology-textbook.com/surgical-management.html">Surgical Management</a></li>
<li><a href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></li>
<li><a href="https://www.urology-textbook.com/ureters.html">Ureters</a></li>
<li><a href="https://www.urology-textbook.com/bladder.html">Bladder</a></li>
<li><a href="https://www.urology-textbook.com/prostate.html">Prostate</a></li>
<li><a href="https://www.urology-textbook.com/urethra.html">Urethra</a></li>
<li><a href="https://www.urology-textbook.com/penis.html">Penis</a></li>
<li><a href="https://www.urology-textbook.com/testes.html">Testes</a></li>
<li><a href="https://www.urology-textbook.com/adrenal-glands.html">Adrenal Glands</a></li>
<li><a href="https://www.urology-textbook.com/common-diseases.html">Common Diseases</a></li>
<li><a href="https://www.urology-textbook.com/urologic-surgery.html">Urologic Surgery</a></li>
<li><a href="https://www.urology-textbook.com/index-urology.html">Index</a></li>
<li><a href="https://www.urology-textbook.com/medical-abbreviations.html">Abbreviations</a></li>
<li><a href="https://www.urology-textbook.com/urology-news.html">News</a></li>
<li><a href="https://www.urology-textbook.com/links.html">Links</a></li>
</ul>

</div>
</nav>

<p id="brotkrumen">&nbsp;You are here: <a href="https://www.urology-textbook.com/index.html">Urology Textbook</a> &gt; <a href="https://www.urology-textbook.com/pharmacology.html">Drugs in Urology</a> &gt; Axitinib</p>

<h1>Axitinib: Indications, Adverse Effects, Contraindications and Dosage</h1>

<h2>Mechanism of Action of Axitinib</h2>

<p>Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3). By blocking VEGFR-mediated signaling, axitinib suppresses pathologic angiogenesis and tumor vascular permeability. Treatment will also lead to <a href="https://www.urology-textbook.com/apoptosis.html">apoptosis of tumor cells</a>. </p>

<h2>Urological Indications for Axitinib</h2>
    <p>Axitinib is indicated for <a href="https://www.urology-textbook.com/renal-cell-carcinoma-targeted-therapy.html">advanced or metastatic renal cell carcinoma</a>. Clinicians use axitinib as monotherapy after disease progression on one prior systemic therapy and, in contemporary practice, as a first-line combination partner with avelumab or <a href="https://www.urology-textbook.com/pembrolizumab.html">pembrolizumab</a>.</p>
    
<p>As second-line monotherapy: A randomized phase 3 trial (AXIS, Rini et al., 2011) demonstrated improved progression-free survival with axitinib versus sorafenib (6.7 vs. 4.7 months).</p>

<h2>Pharmacokinetics of Axitinib</h2>
<p>Administer axitinib orally. Hepatic metabolism (mainly CYP3A4/5). The terminal elimination half-life is approximately 2.5&ndash;6 hours.</p>

<h2>Adverse Effects of Axitinib </h2>

<p>The most common side effects include diarrhea, hypertension, fatigue, dysphonia, nausea, decreased appetite, and palmar–plantar erythrodysesthesia (hand–foot syndrome). Where available, grade &ge;3 incidence appears in parentheses.</p>

<h5>Gastrointestinal tract: </h5>
<p>Diarrhea (10%), vomiting (1&ndash;2%). </p>

<h5>Skin: </h5>
<p>Hand-foot syndrome (5%), mucositis (1&ndash;2%). </p>

<h5>Cardiovascular:</h5>
<p>Hypertension (15%), arterial or venous thromboembolism (2&ndash;3%). </p>

<h5>Other adverse effects: </h5>
<p>Hypothyroidism, lack of appetite (3%), dehydration (2&ndash;3%), fatigue (10%). </p>

<h2>Drug Interactions with Axitinib </h2>

<p>Avoid concomitant use with strong CYP3A4/5 inhibitors (e.g., clarithromycin, ketoconazole, grapefruit) or strong inducers (e.g., rifampin), as they can significantly alter axitinib exposure.</p>

<h2>Contraindications of Axitinib</h2>

<ul title="contraindications of Axitinib">
<li>Severe hepatic impairment (Child-Pugh C)</li>
<li>Pregnancy and lactation</li>
<li>Discontinue axitinib for persistent or recurrent grade 3&ndash;4 toxicity despite dose modifications</li>
</ul>

<h2>Dosage of Axitinib</h2>

<p>Start at 5&nbsp;mg by mouth twice daily (approximately every 12 hours) with or without food. If tolerated, titrate at 1–2-week intervals to 7&nbsp;mg twice daily and then 10&nbsp;mg twice daily. For adverse reactions, reduce stepwise to 3&nbsp;mg twice daily and then 2&nbsp;mg twice daily, or interrupt therapy according to labeling.</p>

<h3>Clinical Controls During Therapy: </h3>

    <p>Measure blood pressure at baseline and regularly thereafter. Periodically obtain a complete blood count, electrolytes, liver function tests, thyroid function, <a href="https://www.urology-textbook.com/creatinine-serum-blood-test.html">serum creatinine</a> and blood glucose. Examine the skin and oral mucosa as clinically indicated.</p>

<h3>Supportive Therapy: </h3>
<p>Treat diarrhea with loperamide. Use gentle mouth rinses for mucositis. Manage hand–foot skin reaction by reducing friction and pressure, and consider keratolytics or low- to mid-potency topical corticosteroids. Treat hypertension with standard antihypertensive therapy. Replace thyroid hormone for hypothyroidism. If toxicity persists, reduce the dose or interrupt therapy.</p>


<br>
<br><div id="ad-footer">
<!-- ad-footer -->
<ins class="adsbygoogle"
     style="display:inline-block;width:500px;height:250px"
     data-ad-client="ca-pub-9284927104423861"
     data-ad-slot="8746163219"></ins>
 <script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
</div>
<br><table id="navigation_unten">
<tr>
<td><a href="https://www.urology-textbook.com/pharmacology.html">Urologic drugs</a></td>
<td><a class="nav4" href="https://www.urology-textbook.com/index.html">Index</a></td>
<td><a href="https://www.urology-textbook.com/bevacizumab.html">Bevacizumab</a></td>
</tr>
</table>

<br>
<br>
Index: <a href="https://www.urology-textbook.com/index-urology-a.html">1&ndash;9</a> <a href="https://www.urology-textbook.com/index-urology-a.html">A</a> <a href="https://www.urology-textbook.com/index-urology-b.html">B</a> <a href="https://www.urology-textbook.com/index-urology-c.html">C</a> <a href="https://www.urology-textbook.com/index-urology-d.html">D</a> <a href="https://www.urology-textbook.com/index-urology-e.html">E</a> <a href="https://www.urology-textbook.com/index-urology-f.html">F</a> <a href="https://www.urology-textbook.com/index-urology-g.html">G</a> <a href="https://www.urology-textbook.com/index-urology-h.html">H</a> <a href="https://www.urology-textbook.com/index-urology-i.html">I</a> <a href="https://www.urology-textbook.com/index-urology-j.html">J</a> <a href="https://www.urology-textbook.com/index-urology-k.html">K</a> <a href="https://www.urology-textbook.com/index-urology-l.html">L</a> <a href="https://www.urology-textbook.com/index-urology-m.html">M</a> <a href="https://www.urology-textbook.com/index-urology-n.html">N</a> <a href="https://www.urology-textbook.com/index-urology-o.html">O</a> <a href="https://www.urology-textbook.com/index-urology-p.html">P</a> <a href="https://www.urology-textbook.com/index-urology-q.html">Q</a> <a href="https://www.urology-textbook.com/index-urology-r.html">R</a> <a href="https://www.urology-textbook.com/index-urology-s.html">S</a> <a href="https://www.urology-textbook.com/index-urology-t.html">T</a> <a href="https://www.urology-textbook.com/index-urology-u.html">U</a> <a href="https://www.urology-textbook.com/index-urology-v.html">V</a> <a href="https://www.urology-textbook.com/index-urology-w.html">W</a> <a href="https://www.urology-textbook.com/index-urology-xyz.html">X Y Z</a> 

<br>
<h3>References</h3>


<p>Rini, B. I.; Escudier, B.; Tomczak, P.; Kaprin, A.; 
        Szczylik, C.; Hutson, T. E.; Michaelson, M. D.; Gorbunova, V. A.; Gore, M. 
        E.; Rusakov, I. G.; Negrier, S.; Ou, Y.; Castellano, D.; Lim, H. Y.; 
        Uemura, H.; Tarazi, J.; Cella, D.; Chen, C.; Rosbrook, B.; Kim, S. &amp; 
        Motzer, R. J.
        Comparative effectiveness of axitinib versus sorafenib in 
        advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.<br><em>Lancet, 
        </em><b>2011</b><i>, 378</i>, 1931-1939.</p>

<br>
<br>
<p><img src="https://images0.urology-textbook.com/deutsch.gif">&nbsp; Deutsche Version: <a href="https://www.urologielehrbuch.de/axitinib.html">Axitinib</a></p>

<h3>Urology-Textbook.com – Choose the Ad-Free, Professional Resource</h3>
<p>This website is designed for physicians and medical professionals. It presents diseases of the genital organs through detailed text and images. Some content may not be suitable for children or sensitive readers. Many illustrations are available exclusively to Steady members. Are you a physician and interested in supporting this project? <a href="https://steady.page/de/urology/about">Join Steady to unlock full access</a> to all images and enjoy an ad-free experience. Try it free for 7 days&mdash;no obligation. </p>

<p><strong>New release:</strong> The first edition of the Urology Textbook as an e-book&mdash;ideal for offline reading and quick reference. With over 1300 pages and hundreds of illustrations, it’s the perfect companion for residents and medical students. After your 7-day trial has ended, you will receive a download link for your exclusive e-book.</p>
</article>
</main>
<footer class="grid">
    <ul id="footer-nav">
    		<li>Copyright by Dr. med. Dirk Manski </li>
		<li><a href="https://www.urology-textbook.com/privacy-policy.html">Privacy policy</a></li>
		<li><a href="https://www.urology-textbook.com/disclaimer.html">Disclaimer</a></li>
	</ul>
	<a class="steady-login-button" data-size="medium" data-language="en" style="display: none;"></a>
	
<img src="https://vg08.met.vgwort.de/na/5d52ef64c3dd48aa9cc8b044b68924e4" width="1" height="1" alt="">


</footer>
</body>
</html>
